All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
MRNA real return snapshot: after CPI-U inflation, MRNA returned +557.69% over the past year and +512.91% YTD, with dividends reinvested. Since Dec. 7, 2018, MRNA is up +655.27% in real purchasing-power return, or +29.46%/yr, and is currently â68.55% below its real total-return high on Aug. 9, 2021.
Data ending Tue Oct. 6, 2026
| Fri 2018-12-07đŹ to Tue 2026-10-06 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+655.27%
+29.46%/yr |
+0.57%/yr
R2=0.000 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07đŹ to Tue 2026-10-06 |
Start
Value |
End
Value |
|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$75,526.69
2026-10-06 |
| YTD | YoY | |
|---|---|---|
| MRNA × | +512.91% | +557.69% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| MRNA × |
â68.55%
on 2026-10-06 from 2021-08-09 peak |
â96.11%
on 2025-11-20 from 2021-08-09 peak |
| Period ending Tue 2026-10-06 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| MRNA × | +557.69% |
+192.18% +70.93%/yr |
+65.25% +18.23%/yr |
â49.33% â12.71%/yr |
— |
| Year | MRNA |
|---|---|
| 2026 (YTD) | +512.91% |
| 2025 | â30.92% |
| 2024 | â59.36% |
| 2023 | â46.43% |
| 2022 | â33.57% |
| 2021 | +127.13% |
| 2020 | +426.92% |
| 2019 | +25.23% |
| 2018 | â17.70% |